Showing results (11-20 of 66) with videos related to
Sort By:
Pageof 7
Analytical Chemistry|October 15, 2011
Approach to evaluating dried blood spot sample stability during drying process and discovery of a treated card to maintain analyte stability by rapid on-card pH modificationGuowen Liu, Qin C Ji, Mohammed Jemal, et al.Journal of Chromatography. A|December 18, 2015
Characterization and quantification of histidine degradation in therapeutic protein formulations by size exclusion-hydrophilic interaction two dimensional-liquid chromatography with stable-isotope labeling mass spectrometryChunlei Wang, Sike Chen, John A Brailsford, et al.Analytical and Bioanalytical Chemistry|November 26, 2010
Advances in mass spectrometry applied to pharmaceutical metabolomicsDieter M Drexler, Michael D Reily, Petia A ShipkovaJournal of Proteome Research|February 3, 2007
Metabonomics in pharmaceutical discovery and developmentDonald G Robertson, Michael D Reily, J David BakerExpert Opinion on Drug Metabolism & Toxicology|July 26, 2006
Metabonomics in preclinical drug developmentDonald G Robertson, Michael D Reily, J David BakerJournal of Chromatography. A|June 12, 2016
Chromatography-based methods for determining molar extinction coefficients of cytotoxic payload drugs and drug antibody ratios of antibody drug conjugatesChunlei Wang, Sike Chen, Janet Caceres-Cortes, et al.Drug Discovery Today|November 25, 2010
Characterization of protein therapeutics by mass spectrometry: recent developments and future directionsGuodong Chen, Bethanne M Warrack, Angela K Goodenough, et al.Journal of Chromatography. A|January 30, 2017
The role of chromatographic and chiroptical spectroscopic techniques and methodologies in support of drug discovery for atropisomeric drug inhibitors of Bruton's tyrosine kinaseJun Dai, Chunlei Wang, Sarah C Traeger, et al.Rapid Communications in Mass Spectrometry : RCM|May 28, 2014
Development of a highly sensitive liquid chromatography/tandem mass spectrometry method to quantify total and free levels of a target protein, interferon-gamma-inducible protein-10, at picomolar levels in human serumHongwei Zhang, Qing Xiao, Baomin Xin, et al.Journal of the American Society for Mass Spectrometry|July 1, 2015
Utility of Ion Mobility Mass Spectrometry for Drug-to-Antibody Ratio Measurements in Antibody-Drug ConjugatesRichard Y-C Huang, Ekaterina G Deyanova, David Passmore, et al.Pageof 7